Measurement and Analysis for Related Costs of Drug-induced Liver Injury from Different Decision Makers
10.6039/j.issn.1001-0408.2017.08.04
- VernacularTitle:从不同决策主体角度测算分析药物性肝损伤的相关成本
- Author:
Cuicui YANG
;
Lixiao ZHANG
;
Jingjing QIN
;
Lizhen ZHANG
;
Shuzhang DU
- Keywords:
Drug-induced liver injury;
Decision maker;
Cost calculation;
Pharmacoeconomics;
Medical insurance
- From:
China Pharmacy
2017;28(8):1023-1026
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To measure and analysis the related costs of drug-induced liver injury (D1LI) from different decision makers,and to provide reference for reducing related costs of DILI,improving medical insurance system and realizing effective health resource distribution.METHODS:In retrospective study,60 cured or recovered DILI inpatieuts were randomly selected as subjects from medical record management system of 4 hospitals in Henan province during Jun.2014-Jun.2015.Demographic character istic,clinical characteristic and related cost of DILI were analyzed retrospectively and the cost structure was also analyzed from different decison makers (patient,society,medical insurance payer).RESULTS:The total direct medical cost of 60 cases was 584 113.05 yuan,and total direct non-medical cost was 31 093.15 yuan and total indirect cost was 169 379.95 yuan.The total cost of DILI of fered by patients was 616 296.38 yuan;the total cost of DILI offered by society was 784 586.15 yuan;the total cost of DILI offered by medical insurance was 168 289.77 yuan.CONCLUSIONS:DILI results in serious economic damage for patients and society,deserving attracting extensive attention worldwide.The study provide reference for reducing patient's medical burden and improving medical insurance system,and contribute to optimize medical resource distribution.
